ENTITY
Moderna

Moderna (MRNA US)

70
Analysis
Health CareUnited States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
Refresh
bullishModerna
12 Aug 2024 14:00

Moderna Inc.: These Are The 4 Biggest Challenges That Bears Are Counting On! - Major Drivers

Moderna reported its Quarterly Earnings recently and managed a decent performance. Positives from the quarter included advancements in Moderna's...

Logo
138 Views
Share
bullishModerna
16 May 2024 01:00

Moderna Inc.: Progress in Personalized Cancer Vaccine (PCV) Manufacturing & Other Major Developments

Moderna Inc.'s first quarter 2024 financial results and business updates indicate a positive forward motion in the development of its business and...

Logo
179 Views
Share
bullishModerna
01 Mar 2024 15:00

Moderna Inc: Initiation Of Coverage - Product Pipeline

This is our first report on Moderna, Inc., a renowned biotechnology company utilizing mRNA technology in the development of therapeutics and...

Logo
336 Views
Share
bullishModerna
28 Feb 2022 06:21

Strong Quarterly Results And New $3B Share Repurchase Plan

Moderna remains our top pick among COVID-19 vaccine producers, and the new buyback program will support share price during periods of turbulent...

Logo
175 Views
Share
bullishModerna
20 Jan 2022 23:30

Is It Time For Moderna To Boost Share Buyback And Start Paying Dividends?

Our analysis suggests that Moderna may boost share buyback and announce dividend payments in 2022 as cash pile will exceed $20 billion

Logo
359 Views
Share
x